Skip to main content

US ClosedU.S. Closed

Healthcare · Biotechnology

INmune Bio, Inc. is a clinical-stage biotechnology company focused on developing novel immunotherapies.

52W Range

88thpctl

Volume

0.34×avg

Market Cap

61.94MUSD

P/E Ratio

-3.4TTM

Div Yield

-ann

Loading chart data...

Current StateState loading

INmune Bio, Inc.

INMBNASDAQ Capital Market·USD·Closed

INmune Bio, Inc.

INMBNASDAQ·USD·Closed

$2.33

−2.92%

$2.33

−$0.07 (2.92%)

52W Range

88thpctl

Volume

0.34×avg

Mkt Cap

61.94MUSD

P/E

-3.4TTM

Div Yield

–ann

INMB: INmune Bio, Inc. Stock Analysis | finqOS